AQR Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.4M | Sell |
|
|||||
|
2025
Q2 | $13.3M | Buy |
|
|||||
|
2025
Q1 | $6.81M | Buy |
|
|||||
|
2024
Q4 | $3.23M | Buy |
|
|||||
|
2024
Q3 | $2.44M | Buy |
|
|||||
|
2024
Q2 | $1.03M | Sell |
|
|||||
|
2024
Q1 | $2.26M | Buy |
|
|||||
|
2023
Q4 | $663K | Sell |
|
|||||
|
2023
Q3 | $682K | Sell |
|
|||||
|
2023
Q2 | $841K | Buy |
|
|||||
|
2023
Q1 | $544K | Buy |
|
|||||
|
2022
Q4 | $669K | Sell |
|
|||||
|
2022
Q3 | $526K | Buy |
|
|||||
|
2022
Q2 | $218K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $552K | Sell |
|
|||||
|
2020
Q3 | $998K | Sell |
|
|||||
|
2020
Q2 | $1.46M | Sell |
|
|||||
|
2020
Q1 | $1.26M | Sell |
|
|||||
|
2019
Q4 | $2.88M | Buy |
|
|||||
|
2019
Q3 | $396K | Buy |
|